Pandemic-era demand for ADHD meds is fueling shortages today
A spike in the use of ADHD medications during the pandemic likely prompted drug shortages that continue to frustrate patients and doctors today, a new study shows.
Jan 11, 2024
0
0
A spike in the use of ADHD medications during the pandemic likely prompted drug shortages that continue to frustrate patients and doctors today, a new study shows.
Jan 11, 2024
0
0
The U.S. Food and Drug Administration approved Tyruko (natalizumab-sztn), the first biosimilar to Tysabri (natalizumab) injection, for the treatment of relapsing forms of multiple sclerosis, the agency announced Thursday.
Aug 27, 2023
0
2
While there is no cure for Alzheimer's, there are medications that can help ease symptoms and slow the progression of this devastating disease.
Jun 21, 2023
0
2
People with attention-deficit/hyperactivity disorder (ADHD) or narcolepsy may rely on the drug Adderall, but it is in short supply, the U.S. Food and Drug Administration announced Wednesday.
Oct 13, 2022
0
6
In a review of more than 3 million pregnancies, University of Florida researchers found 1 in 16 women were exposed to harmful teratogenic drugs—medications that can cause pregnancy loss, birth defects and other health problems ...
Feb 11, 2022
0
5
(HealthDay)—The first biosimilar to Lucentis (ranibizumab injection) has been approved for the treatment of neovascular (wet) age-related macular degeneration and other eye diseases and conditions, the U.S. Food and Drug ...
Sep 24, 2021
0
11
If there's anyone in the United States who can see the future of medicine, it's Dr. Janet Woodcock.
Sep 6, 2019
0
0
Richard Carpenter, 75, was going through the mail one day last year when he saw a postcard from UCI seeking participants for a study on whether exercise can help with age-related memory loss.
Aug 6, 2019
0
22
Richard Carpenter, 75, was going through the mail one day last year when he saw a postcard from UCI seeking participants for a study on whether exercise can help with age-related memory loss.
Jun 4, 2019
0
14
(HealthDay)—The intravenous drug Benlysta (belimumab) has been approved by the U.S. Food and Drug Administration to treat children with lupus, a chronic disease that triggers inflammation and damages tissues and organs ...
Apr 29, 2019
0
2